Mission

The DART Resource Program establishes a centralized hub for the dissemination of ultra-long-acting nanofluidic drug delivery technologies to the HIV research community.

We provide investigators with a drug-agnostic standardized implant platform capable of delivering antiretrovirals with constant, zero-order release kinetics over extended periods.

By providing access to the NanoDDI (Nanofluidic Drug Delivery Implant) technology, we aim to:

• Transform HIV prevention and treatment studies in large preclinical models by eliminating the burst-and-decay drug profiles common in traditional delivery methods.
• Standardize pharmacokinetics profiling across institutions through a uniform, reproducible deployment workflow.
• Enhance animal welfare and reduce operational costs by replacing frequent dosing with a single, transcutaneously refillable implant.
• Expand the landscape of long-acting HIV therapies by benchmarking a broad portfolio of small molecules and biologics.

We offer our implant, specialized training, veterinary support, and protocol optimization to ensure rigorous, reproducible outcomes in your research.